Accolade, Inc. (ACCD)
NASDAQ: ACCD · Real-Time Price · USD
3.150
-0.050 (-1.56%)
Nov 4, 2024, 4:00 PM EST - Market closed

Company Description

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States.

The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians.

It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions.

In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions.

It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs.

The company was incorporated in 2007 and is headquartered in Seattle, Washington.

Accolade, Inc.
Accolade logo
Country United States
Founded 2007
IPO Date Jul 2, 2020
Industry Health Information Services
Sector Healthcare
Employees 2,400
CEO Rajeev Singh

Contact Details

Address:
1201 Third Avenue, Suite 1700
Seattle, Washington 98101
United States
Phone 206 926 8100
Website accolade.com

Stock Details

Ticker Symbol ACCD
Exchange NASDAQ
Fiscal Year March - February
Reporting Currency USD
IPO Price $22.00
CIK Code 0001481646
CUSIP Number 00437E102
ISIN Number US00437E1029
Employer ID 43-2117836
SIC Code 7389

Key Executives

Name Position
Rajeev Singh Chairman of the Board and Chief Executive Officer
Robert Cavanaugh President
Stephen H. Barnes CPA Chief Financial Officer and Treasurer
Richard Eskew Executive Vice President, General Counsel, CCO and Secretary
Kristen Bruzek Senior Vice President of Operations
Colin McHugh Chief Accounting Officer
Todd Friedman Senior Vice President of Investor Relations
Kelsi McDonald Harris Chief People Officer and Senior Vice President
Drew Garner Executive Vice President of Engineering
Dr. Shantanu Nundy M.B.A., M.D. Executive Vice President, Chief Health Officer and Member of the Medical Advisory Board

Latest SEC Filings

Date Type Title
Nov 4, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 4, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Oct 17, 2024 144 Filing
Oct 17, 2024 144 Filing
Oct 17, 2024 144 Filing
Oct 17, 2024 144 Filing
Oct 11, 2024 144 Filing
Oct 11, 2024 144 Filing
Oct 11, 2024 144 Filing
Oct 8, 2024 10-Q Quarterly Report